Abstract
Streptococcus agalactiae can cause multiple infections both in human and animals. Treatment failure caused by antibiotic resistance, however, limits the application of antibiotics. Drugs based on novel strategies, therefore, are needed to fight bacterial infections. Sortase A (SrtA) anchoring surface proteins to the cell wall envelope plays a critical role in Gram-positive bacterial pathogenesis, suggesting that SrtA is a promising target for developing anti-virulence drugs. In this paper, we found that rutin without anti- S. agalactiae activity could reduce adhesion of S. agalactiae to fibronectin and biofilm formation by inhibiting SrtA activity in a dose-dependent manner. Moreover, rutin decreased the adhesion and invasion of S. agalactiae to A549 cells. In vivo study demonstrated that rutin could provide a significant protection against S. agalactiae infection in tilapia. The findings in the present study indicated that rutin is a potent anti-virulence agent against S. agalactiae infections via inhibiting SrtA activity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
